A Canadian information record
A clearer view of weight care in Canada.
Understand services, costs and coverage, with the source behind every record.
How this record is builtStart with your question
Service records last checked 2026-09-23 (next due 2026-09-30). Public coverage records last read 2026-09-16 to 2026-09-27. Every fact carries its own date. What changed
The details matter. So do the gaps.
A company statement, a public-plan listing and a research finding answer different questions. This record keeps them separate.
When sources disagree, both versions stay visible. When a fact has not been found, the page says so.
Maple: where the weight medication assessment is offered
Three Maple pages still disagree. The help page excludes Nova Scotia, Nunavut and the Northwest Territories; the assessment page lists ten jurisdictions; the obesity page says the complimentary membership weight assessment is for Ontario only. Only Ontario appears on all three. Where a page describes whether the assessment is included in membership, that is a benefit question, not the same thing as where the service is offered.
Read both source accountsExplore the record.
Start with where you live, or with what you want to understand.
Your province or territory
13 jurisdiction pages, each showing the depth and limits of its evidence.
The research library
111 study explainers across 13 topics. Review status appears on every page.
Medicines in Canada
Keep product authorization, indication and coverage in separate view.
Ways to access care
Understand documented care routes and the questions still to ask.
What this record is
A maintained record. Each fact is tied to a claim in an evidence ledger, with the source page, the date the source carries, and the date it was read. When a provider's own pages disagree with each other, both versions are shown side by side. When nobody has looked yet, the cell says so.
What this record is not
- Not a clinic, a pharmacy, or a prescribing service. Nobody here assesses you.
- Not a ranking. Services are listed alphabetically, included whether or not they have any relationship with this site (none do).
- Not a coverage checker. It shows what a plan document says; it never tells you whether your claim will be paid.
- Not a stock checker. Regulatory approval is not the same as a product being on a shelf, and this site never says a medicine is on a shelf today.
- Not a dosing or cost calculator. It never multiplies a per-pen price into a month and never picks a dose to finish a sum.
Scope
All ten provinces and three territories from the first version. The evidence is deep for British Columbia and Ontario, moderate for the other eight provinces, and programme-level only for the territories. Where it is thin, the page says so instead of staying silent. Seven online and public services are documented: Felix, Hims, Jill, Maple, Medical Weight Management (BC public program), Phoenix and Pocketpills.
New pages
- Prior authorization forms for weight-loss and GLP-1 medicines added 2026-10-04
- Generic semaglutide in Canada added 2026-10-04
- Orforglipron (Foundayo) in Canada added 2026-10-04
- Retatrutide in Canada added 2026-10-04
- Who can be prescribed Wegovy or Zepbound in Canada added 2026-10-04
- TRIUMPH-1: retatrutide for weight loss over 80 weeks added 2026-10-04
- TRIUMPH-2: retatrutide in adults with obesity and type 2 diabetes added 2026-10-04
- ATTAIN-2: the orforglipron pill for weight loss in type 2 diabetes added 2026-10-04
- ACHIEVE-4: orforglipron and heart safety in type 2 diabetes added 2026-10-04
- Comparing GLP-1 based weight-loss medicines: a 2026 network analysis added 2026-10-04
- GLP-1 weight-loss medicines in adults without diabetes: 2026 review added 2026-10-04
- Wegovy, Ozempic, Mounjaro and Zepbound in Canada added 2026-09-27
Recent changes to the record
- 2026-11-01 (dataset v1.3): Monthly forms check: six Canada Life forms replaced with the 8/26 and 10/26 versions (Zepbound adds an obstructive sleep apnea section; PSHCP Wegovy adds a prior diet or exercise attempt question); Express Scripts Zepbound replaced (wording only); 40 Manulife forms replaced from their new portal addresses (same version codes; online claim steps reworded); Medavie Wegovy, Zepbound and Saxenda official link marked not working; Beneva fingerprints recorded
- 2026-10-11 (dataset v1.3): Obesity Canada links: appeal letter template on the insurance forms page, guideline chapters on the care options page, the October 2026 national report on the coverage page
- 2026-10-04 (dataset v1.3): 111 study explainers: TRIUMPH-1, TRIUMPH-2, ATTAIN-2, ACHIEVE-4 and two 2026 reviews
Accountable authorship. An open method.
An independent record maintained by two pharmacists registered and practising in British Columbia: Arash Pourzare, RPh, owner and editor, and Behnaz Alijani, RPh, co-editor and co-reviewer. Read who is responsible for the work, the review status and the disclosed interests.
Who is behind this, and what they stand to gain